These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 8744592)

  • 21. Contribution of retinoic acid receptor gamma to retinoid-induced craniofacial and axial defects.
    Iulianella A; Lohnes D
    Dev Dyn; 1997 May; 209(1):92-104. PubMed ID: 9142499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of retinoic acid (RA) receptor mRNAs in the fetal mouse secondary palate by all-trans and 13-cis RAs: implications for RA-induced teratogenesis.
    Naitoh H; Mori C; Nishimura Y; Shiota K
    J Craniofac Genet Dev Biol; 1998; 18(4):202-10. PubMed ID: 10100049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.
    Delescluse C; Cavey MT; Martin B; Bernard BA; Reichert U; Maignan J; Darmon M; Shroot B
    Mol Pharmacol; 1991 Oct; 40(4):556-62. PubMed ID: 1656191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
    Tian K; Norris AW; Lin CL; Li E
    Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):319-27. PubMed ID: 9070355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
    García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
    Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential teratogenic response of mouse embryos to receptor selective analogs of retinoic acid.
    Kochhar DM; Jiang H; Penner JD; Beard RL; ChandraratnaAS
    Chem Biol Interact; 1996 Mar; 100(1):1-12. PubMed ID: 8599851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships of retinoids in developmental toxicology. III. Contribution of the vitamin A beta-cyclogeranylidene ring.
    Howard WB; Willhite CC; Dawson MI; Sharma RP
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):122-38. PubMed ID: 3413791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of beta-retinoic acid receptor mRNA by teratogenic doses of retinoids in murine fetuses.
    Harnish DC; Barua AB; Soprano KJ; Soprano DR
    Differentiation; 1990 Nov; 45(2):103-8. PubMed ID: 1965892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional activation of a model reporter system by retinoids and retinoic acid receptor isoforms.
    Huggenvik JI; Sharma RP
    Pharmacol Toxicol; 1995 Jan; 76(1):17-22. PubMed ID: 7753751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished teratogenicity of retinoid X receptor-selective synthetic retinoids.
    Jiang H; Penner JD; Beard RL; Chandraratna RA; Kochhar DM
    Biochem Pharmacol; 1995 Aug; 50(5):669-76. PubMed ID: 7669070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma.
    Meister B; Fink FM; Hittmair A; Marth C; Widschwendter M
    Anticancer Res; 1998; 18(3A):1777-86. PubMed ID: 9673404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teratology of retinoids.
    Collins MD; Mao GE
    Annu Rev Pharmacol Toxicol; 1999; 39():399-430. PubMed ID: 10331090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative developmental toxicity potencies of retinoids in the embryonic stem cell test compared with their relative potencies in in vivo and two other in vitro assays for developmental toxicity.
    Louisse J; Gönen S; Rietjens IM; Verwei M
    Toxicol Lett; 2011 May; 203(1):1-8. PubMed ID: 21362465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The retinoid receptors.
    Pemrick SM; Lucas DA; Grippo JF
    Leukemia; 1994; 8 Suppl 3():S1-10. PubMed ID: 7808017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.
    Howell SR; Shirley MA; Ulm EH
    Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-affinity relationships of retinoids with embryonic cellular retinoic acid-binding protein.
    Willhite CC; Jurek A; Sharma RP; Dawson MI
    Toxicol Appl Pharmacol; 1992 Jan; 112(1):144-53. PubMed ID: 1310166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs.
    Brooks SC; Kazmer S; Levin AA; Yen A
    Blood; 1996 Jan; 87(1):227-37. PubMed ID: 8547646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure.
    Arafa HM; Elmazar MM; Hamada FM; Reichert U; Shroot B; Nau H
    Arch Toxicol; 2000 Jan; 73(10-11):547-56. PubMed ID: 10663386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.